Lagis Enterprise Co., Ltd. (TPEX:6730)
30.70
+0.60 (1.99%)
Nov 20, 2026, 12:32 PM CST
Lagis Enterprise Revenue
Lagis Enterprise had revenue of 132.77M TWD in the quarter ending September 30, 2026, with 5.04% growth. This brings the company's total for the last twelve months to 498.72M, up 6.04% year-over-year. In the year 2025, Lagis Enterprise had annual revenue of 487.65M with 7.33% growth. That makes Lagis Enterprise the 35,433rd largest company in the world by revenue and 1,839th in Taiwan.
Revenue (ttm)
498.72M
Revenue Growth
+6.04%
P/S Ratio
2.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.11B
Revenue by Geography
- Other Countries 162.56M 33.3%
- Japan 127.17M 26.1%
- Taiwan 112.10M 23.0%
- South Korea 45.42M 9.3%
- Spain 40.40M 8.3%
Fiscal year ended Dec 31, 2025 See the full Lagis Enterprise breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 487.65M | 33.29M | 7.33% |
| Dec 31, 2024 | 454.36M | -5.58M | -1.21% |
| Dec 31, 2023 | 459.93M | 17.75M | 4.01% |
| Dec 31, 2022 | 442.19M | 49.15M | 12.50% |
| Dec 31, 2021 | 393.04M | 73.68M | 23.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.40B |
| Nang Kuang Pharmaceutical | 2.09B |
| Chi Sheng Pharma & Biotech | 1.43B |
| ICARES Medicus | 1.31B |
| Concord Medical | 1.04B |
| Crystalvue Medical | 894.60M |
| Perfect Medical Industry | 886.30M |
| SciVision Biotech | 870.41M |